Atlas Trials

Evaluation of Influenza A/H3N2 Vaccine in Patients With Rheumatologic Diseases

Clinical trial NCT03540823 · COMPLETED

Trial details

NCT number
NCT03540823
Sponsor
University of Sao Paulo General Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Systemic LupusSjogren's Syndrome
Start date
2018-04-23
Primary completion
2018-06-23
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.